Key Takeaway: argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+42%
120-day peak, hindsight
Typical move
4%
average across 14 past catalysts
Lead asset
Empasiprubart
Phase 2 · Dermatomyositis
Full Press Release Details
argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017.